OTCMKTS:MYDP - Dougherty's Pharmacy Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.0943 0.00 (0.00 %)
(As of 05/23/2018 01:28 AM ET)
Previous Close$0.0943
Today's Range$0.0943 - $0.0943
52-Week Range$0.0686 - $0.28
Volume4,021 shs
Average Volume4,341 shs
Market Capitalization$2.12 million
P/E RatioN/A
Dividend YieldN/A

About Dougherty's Pharmacy (OTCMKTS:MYDP)

Dougherty's Pharmacy, Inc., an investment firm, focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1998 and is based in Dallas, Texas.

Receive MYDP News and Ratings via Email

Sign-up to receive the latest news and ratings for MYDP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores


Debt-to-Equity Ratio1.97
Current Ratio0.73
Quick Ratio0.31


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$40.21 million
Price / Sales0.05
Cash FlowN/A
Price / CashN/A
Book Value$0.07 per share
Price / Book1.35


EPS (Most Recent Fiscal Year)N/A
Net Income$-2,100,000.00
Net Margins-5.57%
Return on Equity-53.36%
Return on Assets-9.06%


Outstanding Shares23,090,000

Dougherty's Pharmacy (OTCMKTS:MYDP) Frequently Asked Questions

What is Dougherty's Pharmacy's stock symbol?

Dougherty's Pharmacy trades on the OTCMKTS under the ticker symbol "MYDP."

How were Dougherty's Pharmacy's earnings last quarter?

Dougherty's Pharmacy Inc (OTCMKTS:MYDP) posted its earnings results on Friday, May, 11th. The company reported ($0.01) earnings per share for the quarter. The firm earned $9.46 million during the quarter. Dougherty's Pharmacy had a negative return on equity of 53.36% and a negative net margin of 5.57%. View Dougherty's Pharmacy's Earnings History.

When is Dougherty's Pharmacy's next earnings date?

Dougherty's Pharmacy is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Dougherty's Pharmacy.

Who are some of Dougherty's Pharmacy's key competitors?

Who are Dougherty's Pharmacy's key executives?

Dougherty's Pharmacy's management team includes the folowing people:
  • Mr. James C. Leslie CPA, Chairman, Interim Pres & Interim CFO (Age 63)
  • Ms. Katherine Burrow, Managing Director of Bus. Devel.
  • Ms. Susan K. Olson, Sec.
  • Ms. Robin Bruce CPA, Controller
  • Mr. Rick Troberman, Exec. VP of Sales and Marketing

Has Dougherty's Pharmacy been receiving favorable news coverage?

Headlines about MYDP stock have trended somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dougherty's Pharmacy earned a news impact score of 0.18 on Accern's scale. They also assigned news stories about the company an impact score of 45.53 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Dougherty's Pharmacy?

Shares of MYDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dougherty's Pharmacy's stock price today?

One share of MYDP stock can currently be purchased for approximately $0.0943.

How big of a company is Dougherty's Pharmacy?

Dougherty's Pharmacy has a market capitalization of $2.12 million and generates $40.21 million in revenue each year. Dougherty's Pharmacy employs 105 workers across the globe.

How can I contact Dougherty's Pharmacy?

Dougherty's Pharmacy's mailing address is 5924 ROYAL LANE SUITE 250, DALLAS TX, 75230. The company can be reached via phone at 972-250-0945 or via email at [email protected]

MarketBeat Community Rating for Dougherty's Pharmacy (MYDP)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Dougherty's Pharmacy and other stocks. Vote "Outperform" if you believe MYDP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYDP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Dougherty's Pharmacy (OTCMKTS:MYDP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/23/2016 forward)


Dougherty's Pharmacy (OTCMKTS:MYDP) Earnings History and Estimates Chart

Earnings by Quarter for Dougherty`s Pharmacy (OTCMKTS:MYDP)

Dougherty's Pharmacy (OTCMKTS MYDP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/11/2018Q1 2018($0.01)$9.46 millionViewN/AView Earnings Details
3/29/2018Q4 2017($0.01)$10.00 millionViewN/AView Earnings Details
11/10/2017Q3 2017($0.02)$9.95 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.01)$10.21 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.01)$10.06 millionViewN/AView Earnings Details
3/21/2017Q4 2016($0.07)$10.48 millionViewN/AView Earnings Details
11/10/2016Q3 2016($0.01)$10.49 millionViewN/AView Earnings Details
8/18/2016Q2 2016($0.01)$11.00 millionViewN/AView Earnings Details
5/13/2016Q1 2016($0.01)$10.82 millionViewN/AView Earnings Details
5/21/2015Q1 2015($0.01)$9.02 millionViewN/AView Earnings Details
11/13/2014Q3 2014$0.01ViewN/AView Earnings Details
8/20/2014Q2 2014$0.01$6.70 millionViewN/AView Earnings Details
3/3/2014Q4 2013$0.01ViewN/AView Earnings Details
11/15/2013Q3 2013$0.01ViewN/AView Earnings Details
8/19/2013Q2 2013($0.01)ViewN/AView Earnings Details
5/23/2013Q1 2013$0.02ViewN/AView Earnings Details
8/22/2012Q2 2012($0.01)ViewN/AView Earnings Details
6/5/2012Q1 2012($0.01)ViewN/AView Earnings Details
4/4/2012Q4 2011($0.03)ViewN/AView Earnings Details
11/10/2011Q3 2011($0.01)ViewN/AView Earnings Details
8/10/2011Q2 2011$0.01ViewN/AView Earnings Details
5/25/2011Q1 2011($0.03)ViewN/AView Earnings Details
3/30/2011Q4 2010$0.05ViewN/AView Earnings Details
11/11/2010Q3 2010$0.01ViewN/AView Earnings Details
8/11/2010Q2 2010$0.01ViewN/AView Earnings Details
5/12/2010Q1 2010$0.02ViewN/AView Earnings Details
5/13/2009Q1 2009$0.01ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Dougherty's Pharmacy (OTCMKTS:MYDP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Dougherty's Pharmacy (OTCMKTS MYDP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 27.30%
Institutional Ownership Percentage: 0.49%
Insider Trading History for Dougherty`s Pharmacy (OTCMKTS:MYDP)

Dougherty's Pharmacy (OTCMKTS MYDP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Dougherty's Pharmacy (OTCMKTS MYDP) News Headlines

No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Dougherty's Pharmacy (OTCMKTS:MYDP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Dougherty's Pharmacy (OTCMKTS:MYDP) Income Statement, Balance Sheet and Cash Flow Statement


Dougherty's Pharmacy (OTCMKTS MYDP) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.